Russell Frank Company’s Bristol-Myers Squibb BMY Stock Holding History

Russell Frank Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$148M	Sell	2,319,314 -305,381	-12%	-$19.3M	0.26%	76
2015 Q4	$183M	Sell	2,624,695 -278,831	-10%	-$18.4M	0.32%	63
2015 Q3	$172M	Sell	2,903,526 -194,959	-6%	-$12.4M	0.32%	59
2015 Q2	$206M	Buy	3,098,485 +636,818	+26%	+$42M	0.33%	60
2015 Q1	$159M	Sell	2,461,667 -477,596	-16%	-$29.9M	0.29%	66
2014 Q4	$175M	Sell	2,939,263 -675,528	-19%	-$38.1M	0.31%	68
2014 Q3	$185M	Buy	3,614,791 +162,955	+5%	+$8.14M	0.33%	63
2014 Q2	$175M	Buy	3,451,836 +794,308	+30%	+$39.1M	0.31%	71
2014 Q1	$138M	Buy	2,657,528 +883,925	+50%	+$47M	0.24%	92
2013 Q4	$89.1M	Buy	1,773,603 +398,922	+29%	+$20.3M	0.16%	141
2013 Q3	$63.6M	Sell	1,374,681 -95,475	-6%	-$4.19M	0.11%	210
2013 Q2	$65.7M	Buy	+1,470,156	New	+$63.8M	0.12%	206

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Russell Frank Company's BMY Position: Q1 2016 in Review

Russell Frank Company reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2016, selling an estimated $19.3M and leaving 2,319,314 shares worth $148M. The position accounts for 0.26% of the portfolio, ranked #76.

Russell Frank Company first reported a position in BMY in Q2 2013 and has held it in 12 quarters since. The position peaked at $206M in Q2 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

Russell Frank Company held 2,319,314 shares of Bristol-Myers Squibb worth $148M as of Q1 2016.
Russell Frank Company sold 305,381 Bristol-Myers Squibb shares in Q1 2016, an estimated $19.3M.
Bristol-Myers Squibb made up 0.26% of Russell Frank Company's portfolio in Q1 2016, its #76 holding.
Russell Frank Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Bristol-Myers Squibb position peaked at $206M in Q2 2015.
1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.